Global Health
add_icon

Global Health

1,237.40
-12.60
(-1.01%)
Market Cap
₹33,260.12 Cr
PE Ratio
58.06
Volume
56,777.00
Day High - Low
₹1,258.60 - ₹1,233.70
52W High-Low
₹1,456.50 - ₹996.45
ann
There are new updates from the company18 hours ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
33,260.12 Cr
EPS
17.92
PB Ratio
8.79
Book Value
137.94
EBITDA
956.20
Dividend Yield
0.00 %
Sector
Hospitals
ROE Growth %
-
Debt to Equity
0.24
Analyst Rating and Forecast
- By Refinitiv from11 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+63.64 %
+63.64 %
Hold
Hold+27.27 %
+27.27 %
Sell
Sell+9.09 %
+9.09 %
Forecast For
Actual

Company News

View All News
Caret
positive
Global Health has expanded its operations in the National Capital Region by launching a new 550-bed super specialty hospital in Noida. This expansion strengthens the company's healthcare infrastructure presence in the NCR market.
positive
Medanta Reports 15% Revenue Growth in Q2FY26, Opens New 550-Bed Noida HospitalNov 13, 2025
Global Health Limited (Medanta) posted consolidated revenue of INR 11,189 million for Q2FY26, up 15% year-on-year, with PAT growing 21% to INR 1,584 million and margins improving to 14.2%. The company commenced operations at its sixth facility, a 550-bed Noida hospital in September 2025, which generated INR 39 million revenue but reported EBITDA loss of INR 197 million in its first month of operations.
positive
Global Health Limited (Medanta) launched a new 550-bed super specialty hospital in Noida in September 2025, strengthening its presence in Delhi/NCR. The company reported consolidated total income of INR 11,189 million in Q2 FY26, up 14.8% year-on-year and 6.4% quarter-on-quarter. EBITDA excluding Noida grew 13.7% year-on-year to INR 2,804 million with margins of 25.2%. Net profit increased 21.1% year-on-year to INR 1,584 million. The Noida facility generated revenue of INR 39 million but recorded an EBITDA loss of INR 197 million during initial operations. The company added 37 new beds at Patna during the quarter and onboarded over 200 doctors across its network. International patient revenue increased 48.5% year-on-year to INR 762 million. The company also announced plans for a 750-bed hospital in Mumbai with an estimated project cost of INR 15,300 million and acquired 3.5 acres in Guwahati for INR 600 million for future expansion.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,161.80
#1 1,12,954.43
83.67
7,184.10
#1 28.65
1,076
#1 74.34
53.89
7,319.50
1,05,243.18
61.72
#1 21,994.30
14.76
#1 1,505
24.84
35.14
910.20
68,716.29
68.04
7,849.70
13.25
809
70.27
34.06
1,946.10
39,770.66
48.80
5,575.00
12.29
790
30.03
58.50
660.20
34,206.35
94.45
4,286.70
15.12
337
14.65
45.93
1,237.40
#6 33,260.12
#4 58.06
#6 3,771.40
#8 12.59
#5 481
#6 21.10
48.05
683.65
27,355.50
75.73
3,067.00
21.98
415
-40.35
45.74
528.70
16,715.29
107.45
1,757.00
27.64
110
71.36
58.70
5,996.95
15,303.73
#1 28.77
599.90
11.69
58
16.17
35.32
1,350.20
13,712.52
53.31
1,566.90
17.46
244
-4.30
51.13
Growth Rate
Revenue Growth
12.59 %
Net Income Growth
0.67 %
Cash Flow Change
1.91 %
ROE
-13.62 %
ROCE
-9.67 %
EBITDA Margin (Avg.)
-2.80 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
492
588
593
533
627
695
706
732
795
865
855
836
883
975
960
954
1,051
1,119
Expenses
386
442
448
441
485
523
534
540
595
631
621
629
675
728
706
757
784
852
EBITDA
106
146
146
92
142
172
172
192
199
234
234
207
208
247
254
198
267
267
Operating Profit %
21 %
24 %
23 %
15 %
21 %
23 %
23 %
24 %
24 %
25 %
26 %
22 %
22 %
24 %
25 %
19 %
24 %
22 %
Depreciation
31
31
33
35
36
37
39
38
40
43
44
46
47
49
49
49
45
50
Interest
16
17
18
28
19
18
21
21
18
20
18
18
18
16
16
15
14
17
Profit Before Tax
58
98
95
29
87
117
112
133
141
171
172
143
144
181
189
133
208
200
Tax
16
31
25
12
28
31
32
32
39
45
49
16
37
50
46
32
49
41
Net Profit
42
67
70
18
59
86
81
101
102
125
124
127
106
131
143
101
159
158
EPS in ₹
5.13
13.22
2.76
0.69
2.32
3.38
3.08
3.77
3.80
4.66
4.61
4.74
3.96
4.87
5.32
3.77
5.92
5.89

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,984
2,430
0
2,694
3,146
4,116
4,304
4,766
Fixed Assets
1,094
1,194
0
1,616
1,776
2,050
2,236
2,514
Current Assets
472
489
0
502
812
1,580
1,509
1,533
Capital Work in Progress
317
666
0
464
439
327
388
533
Investments
0
0
0
0
0
0
0
3
Other Assets
573
570
0
615
930
1,739
1,681
1,716
Total Liabilities
1,984
2,430
0
2,694
3,146
4,116
4,304
4,766
Current Liabilities
334
296
0
405
420
573
618
619
Non Current Liabilities
432
839
0
907
1,110
1,115
781
760
Total Equity
1,217
1,296
0
1,382
1,616
2,428
2,906
3,388
Reserve & Surplus
1,136
1,214
0
1,300
1,565
2,375
2,852
3,333
Share Capital
81
49
0
50
51
54
54
54

Cash Flow

Cash Flow
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-20
3
14
87
-78
50
648
-343
-194
Investing Activities
-126
-241
-69
-249
-87
-239
-421
-342
-441
-721
Operating Activities
213
228
63
166
175
242
311
645
612
624
Financing Activities
-88
-7
9
97
-1
-81
160
346
-514
-97

Share Holding

% Holding
Sept 2021
Oct 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
35.04 %
35.03 %
33.08 %
33.08 %
33.08 %
33.07 %
33.06 %
33.05 %
33.04 %
33.04 %
33.04 %
33.03 %
33.03 %
33.01 %
33.01 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.69 %
0.00 %
12.09 %
12.94 %
12.20 %
12.47 %
11.76 %
11.54 %
11.40 %
DIIs
0.00 %
0.00 %
7.78 %
12.55 %
12.35 %
10.80 %
10.93 %
9.68 %
10.25 %
10.57 %
11.11 %
10.51 %
11.93 %
12.20 %
12.98 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
25.44 %
6.16 %
5.77 %
6.79 %
6.85 %
6.79 %
7.14 %
6.28 %
6.54 %
6.74 %
6.53 %
6.48 %
6.03 %
Others
64.96 %
64.97 %
33.69 %
48.21 %
48.80 %
49.34 %
38.48 %
50.48 %
37.47 %
37.16 %
37.10 %
37.24 %
36.75 %
36.77 %
36.58 %
No of Share Holders
47
48
2,86,944
1,21,407
1,07,120
1,09,798
1,16,627
1,24,775
1,66,253
1,55,307
1,49,722
1,48,633
1,54,688
1,56,372
1,55,806

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
03 Aug 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
03 Aug 2024 1,306.70 1,209.25
19 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2024 1,191.50 1,113.90
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 1,073.35 1,032.55
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 1,001.20 1,042.50
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,203.60 1,241.80
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 1,355.40 1,339.10
22 Aug 2025 DIVIDEND Dividend
₹ 0.50 /share
22 Aug 2025 1,241.80 1,389.30
19 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2025 1,339.10 1,367.70
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2025 1,348.70 1,280.70

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media Release18 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 07, 2025
Announcement Under Regulation 30 Of Listing Regulations.Nov 07, 2025
Results For The Quarter & Half Year Ended September 30 2025Nov 07, 2025
Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing RegulationNov 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 01, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 31, 2025
Board Meeting Intimation for Schedule Of Board Meeting For Second Quarter And Half Year Ended September 30 2025 Under Regulation 29 Of Listing RegulationsOct 28, 2025
Announcement Under Regulation 30 Of Listing Regulations.Oct 25, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 17, 2025
Disclosure under Regulation 30A of LODROct 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) - ESG Rating Assigned By CRISILOct 07, 2025
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Oct 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 25, 2025
Closure of Trading WindowSep 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 24, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 19, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2025
Announcement Under Regulation 30 Of Listing RegulationsSep 04, 2025
Announcement Under Regulation 30 Of Listing RegulationsSep 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Kotak Midcap Fund Direct-Growth
1.83%
900010
0.14%
0.02%
Invesco India Multicap Fund Direct-Growth
1.94%
211758
0.61%
0.54%
UTI Mid Cap Fund Direct-Growth
0.76%
200000
0.20%
0.59%
UTI Flexi Cap Fund Direct-Growth
1.59%
57600
-0.01%
0.09%
Kotak Contra Fund Direct-Growth
1.34%
45000
0.06%
-0.06%
UTI India Consumer Fund Direct-Growth
1.61%
21340
0.35%
0.29%
WhiteOak Capital Quality Equity Fund Direct-Growth
1.34%
4537
0.01%
-0.08%
PGIM India Healthcare Fund Direct-Growth
2.93%
-2570
-0.39%
-0.46%
Motilal Oswal Nifty Midcap 150 Index Fund Direct - Growth
0.29%
1374
-0.01%
-0.04%
PGIM India Aggressive Hybrid Equity Fund Direct-Growth
2.28%
-1090
-0.07%
-0.19%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
0.30%
570
-0.01%
-0.04%
ICICI Prudential Nifty Midcap 150 Index Fund Direct - Growth
0.29%
563
-0.01%
-0.04%
SBI Nifty Midcap 150 Index Fund Direct - Growth
0.29%
-416
-0.02%
-0.05%
Zerodha Nifty Large Midcap 250 Index Fund Direct - Growth
0.15%
324
-0.01%
-0.02%
HDFC NIFTY Midcap 150 Index Fund Direct - Growth
0.29%
238
-0.02%
-0.05%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.06%
189
0.00%
-0.01%
HDFC Nifty LargeMidcap 250 Index Fund Direct-Growth
0.15%
-161
0.00%
-0.02%
Navi Nifty Midcap 150 Index Fund Direct - Growth
0.29%
147
-0.02%
-0.05%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.19%
128
-0.01%
-0.06%
Motilal Oswal Quant Fund Direct-Growth
1.08%
-122
-0.05%
-0.12%
Nippon India Nifty Midcap 150 Index Fund Direct - Growth
0.29%
-115
-0.02%
-0.05%
SBI Nifty 500 Index Fund Direct-Growth
0.06%
-110
0.00%
-0.01%
Zerodha ELSS Tax Saver Nifty Large Midcap 250 Index Fund Direct - Growth
0.15%
42
-0.01%
-0.02%
Kotak Nifty Midcap 150 Index Fund Direct - Growth
0.29%
39
-0.02%
-0.04%
UTI Nifty Midcap 150 Index Fund Direct-Growth
0.30%
34
-0.01%
-0.04%

Technical Indicators

RSI(14)
Neutral
48.05
ATR(14)
Volatile
35.38
STOCH(9,6)
Overbought
84.05
STOCH RSI(14)
Overbought
95.94
MACD(12,26)
Bullish
9.89
ADX(14)
Weak Trend
24.87
UO(9)
Bearish
60.38
ROC(12)
Uptrend But Slowing Down
6.57
WillR(14)
Neutral
-25.75

About Global Health

Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over 30 medical specialties, employed over 1,300 doctors, and had 2,467 installed beds across 4.7 million sq. ft. of area. The company operates hospitals in Gurugram, Indore, Ranchi, Lucknow, and Patna, with specialties including cardiology, neurosciences, oncology, and orthopedics. Global Health Limited went public in November 2022, raising Rs. 2205.57 crores through an IPO. The company has been expanding its facilities, adding beds, doctors, and new medical equipment across its hospitals.
Listing Date
16 Nov, 2022(3 Years, 12 days)
Chairperson NameNaresh Kumar Trehan